carmustine has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geyer, JR | 1 |
Zeltzer, PM | 1 |
Boyett, JM | 1 |
Rorke, LB | 1 |
Stanley, P | 1 |
Albright, AL | 1 |
Wisoff, JH | 1 |
Milstein, JM | 1 |
Allen, JC | 1 |
Finlay, JL | 1 |
Watne, K | 1 |
Hager, B | 1 |
2 other studies available for carmustine and (pPNET) Peripheral Primitive Neuroectodermal Tumors
Article | Year |
---|---|
Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cyclophospha | 1994 |
Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Female; Humans; Infusio | 1987 |